tiakis Biotech AG
PrivateLast Round
Series A
Oct 15, 2021
Company Overview
tiakis Biotech AG operates in Healthcare & Life Sciences and is based in Kiel. Its latest recorded funding round was a Series A round in October 2021.
tiakis Biotech AG is a biotechnology company that develops anti-inflammatory and tissue-protective therapeutic drugs for pulmonary and cardiovascular diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
tiakis Biotech AG Comparables
Compare tiakis Biotech AG with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cereno Scientific | 79% | |
| GSK plc | 75% | |
| Ono Pharmaceutical Co., Ltd. | 71% |
For institutional investors. Book with your work email.
tiakis Biotech AG Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
tiakis Biotech AG Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Elevat3 Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 2, 2026
Monthly visitors grew 308% MoM, reaching 1.6K.
For institutional investors. Book with your work email.
tiakis Biotech AG Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about tiakis Biotech AG's valuation, stock price, and market status.
Is tiakis Biotech AG a public or private company?
tiakis Biotech AG is a private company.
What is the current stock price of tiakis Biotech AG?
tiakis Biotech AG is a private company, so its shares have no public market price. Caplight tracks tiakis Biotech AG's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is tiakis Biotech AG worth (valuation)?
Valuation information for tiakis Biotech AG is not publicly available.
Can I buy tiakis Biotech AG stock?
tiakis Biotech AG shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was tiakis Biotech AG's last funding round?
tiakis Biotech AG's most recent funding round was Series A on October 15, 2021.
Who are the main investors in tiakis Biotech AG?
Key investors in tiakis Biotech AG include Elevat3 Capital.
Will tiakis Biotech AG IPO soon?
No public IPO plans have been announced for tiakis Biotech AG.
How can I track tiakis Biotech AG secondary market activity?
Caplight tracks bids, offers, and trades in tiakis Biotech AG's shares on secondary markets.